Today's Highlights

Breakfast and Poster Viewing | 7:00 a.m. - 8:00 a.m.

Exhibit Hall | 7:00 a.m. - 5:30 p.m.

Welcome | 7:50 a.m. - 8:00 a.m., Vickie Shannon, MD, MD Anderson Cancer Center

Major Challenges and Opportunities Facing Us in 2023 | 8:00 a.m. - 8:30 a.m. Moderator: Zhongxing Liao, MD, FASTRO, MD Anderson Cancer Center

The Emerging Benefits of Immunotherapy and Targeted Therapy | 8:30 a.m. - 10:00 a.m. Moderator: Jamie Chaft, MD, Memorial Sloan Kettering Cancer Center

Pearls, Pitfalls and Challenges in Toxicities Associated with Immunotherapy and Targeted Therapies: What We Know Now | 10:30 a.m. - 11:30 a.m. Moderator: Vickie Shannon, MD, MD Anderson Cancer Center

Breakout sessions | 11:30 a.m. - 12:15 p.m.

• Modern Substance Use Disorders – What's NOT on the Med List? | Napoleon Ballroom AB
• Early Detection | Borgne Room

Trainee and Early Career Networking Luncheon | 12:15 p.m. - 1:30 p.m.

Plenary Session | 1:30 p.m. - 3:00 p.m. Moderator: David Carbone, MD, PhD, The Ohio State University

The Changing Landscape of Lung Cancer Biomarkers | 3:30 p.m. - 4:30 p.m. Moderator: Kurt Schalper, MD, Yale University

Networking Reception and Poster Q&A Session | 4:30 p.m. - 5:30 p.m.

Industry-Expert Theater | AstraZeneca | 5:30 p.m. - 6:30 p.m.

The Thoracic Symposium offers scientific studies featuring cutting-edge research relevant to the entire thoracic cancer community. Find full text of the abstracts (after the embargo lifts today, November 30, at 8:00 a.m. Central time) on the meeting website and in the January issue of the International Journal of Radiation Oncology · Biology · Physics (www.redjournal.org).

In New Orleans? Plan to stop by one of the Poster Q&A sessions to see presentations and mingle with faculty, other attendees and industry representatives in the Exhibit Hall. New this year, every poster author has the opportunity to present during the following scheduled sessions:

• Poster Q&A 01: Thursday, November 30, 4:30 p.m. - 5:30 p.m.
• Poster Q&A 02: Friday, December 1, 9:30 a.m. - 10:00 a.m.
• Poster Q&A 03: Friday, December 1, 2:15 p.m. - 2:45 p.m.

All posters are also accessible online in the Virtual Poster Library. The library will be available during the symposium and for a limited time after the symposium concludes.

ASTRO offers 17 brochures on general radiation therapy and disease-site specific topics that are available for download and to purchase from the product catalog. These brochures were created to help physicians provide information to people with cancer and their families about the treatment options available. See these and ASTRO’s other patient-focused resources as well as presentations designed to inform health care professionals about radiation therapy.

The guideline emphasizes the need for a multidisciplinary team approach to guide treatment decisions for oligometastatic disease. Treatment for oligometastatic NSCLC historically involved systemic therapy such as chemotherapy or immunotherapy, with local therapy given only for palliation and symptom relief. A growing body of research, however, points to an additional role for definitive local therapy to all disease sites, aiming at durable tumor control and improved survival outcomes. The guideline addresses patient selection, treatment planning and delivery techniques for definitive local therapy to manage oligometastatic NSCLC, emphasizing the need for patient-centered, multidisciplinary decision making. The guideline task force also created algorithms on the optimal clinical scenarios for local therapy and the different types of local therapy available for these patients.

The multidisciplinary guideline task force included radiation, medical and surgical oncologists, a radiation oncology resident, a pulmonologist, thoracic surgeons, a medical physicist and a patient representative. The guideline was based on a systematic literature review of articles published through February 2022.

See the full guideline and review the key questions and recommendations in Practical Radiation Oncology.

Highlighting key information from SITC’s published guidelines, the SITC CPG Mobile App features important aspects of immunotherapy treatment as well as interactive tools and companion educational resources.

Learn more about the SITC guidelines and mobile app.

Social Q&A

• Submit questions, see what others are asking during presentations and upvote your favorite questions — no download required! Bookmark astro.org/ThoracicSocialQA and navigate to the current session for interaction. Use your phone, tablet or computer to submit questions online to the speakers and moderators during sessions.

Networking opportunities

• Exhibit Hall and Poster Viewing: Connect with colleagues and industry representatives while visiting exhibit booths and viewing posters during the scheduled breakfasts, lunches and coffee breaks in the Exhibit Hall in Napoleon Ballroom CD.
• Trainee and Early Career Networking Luncheons: These provide an invaluable opportunity to speak with and learn from experts in the lung cancer care community. Early Career attendees (defined for this symposium as any attendee who is less than three years out of their training) will gain meaningful insight into career paths and development that will help support you in your medical career.
  • Thursday, 12:15 p.m. - 1:30 p.m. | Choosing Your Career Path
  • Friday, 11:45 a.m. - 1:00 p.m. | Launching Your Successful Career
• ROhub Community: Continue conversations with other attendees and watch for meeting alerts and updates from the exclusive ROhub community (for registered in-person and virtual attendees only).

Passport to Prizes

• Visit participating booths in the Exhibit Hall and receive a stamp in your passport (you’ll be given a passport when you pick up your registration materials).
• All stamps must be completed on the passport for eligibility.
• The drawing will take place tomorrow at 2:45 p.m. at the start of the General Session in Napoleon Ballroom AB.
• Two winners will receive a $100 AMEX gift card!